TLSI (TLSI) Stock Price & Analysis
TLSI (TLSI) fell 5.40% to USD 4.73 as of September 9, 2026 at 12:04 UTC, according to Nexqual real-time market data.
TLSI last closed at USD 5; the session ranged USD 4.48–4.94 on volume of 128,884 shares. Market capitalization is $291.25M, with a 52-week range of USD 2.2–7.95 (NGM). Source: Nexqual, September 9, 2026 at 12:04 UTC.
Key Statistics (as of September 9, 2026 at 12:04 UTC)
| Price | USD 4.73 |
|---|---|
| Change | ▼ 5.40% (down) |
| Previous Close | USD 5 |
| Open | USD 4.94 |
| Day Range | USD 4.48 – 4.94 |
| 52-Week Range | USD 2.2 – 7.95 |
| Volume | 128,884 shares |
| Market Cap | $291.25M |
| Exchange | NGM |
Technical Analysis (TLSI)
Nexqual's technical model rates TLSI "SELL" based on 1 bullish and 4 bearish signals across 127 daily candles, as of September 9, 2026 at 12:04 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.71 (neutral) |
| vs SMA50 | Below (USD 4.74) |
| MACD | 0.03 (positive) |
Analyst Ratings (TLSI)
Wall Street analysts rate TLSI "Strong Buy" based on 4 analysts, with a mean price target of USD 10 (range USD 7–14), per Nexqual as of September 9, 2026 at 12:04 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 10 |
| High Target | USD 14 |
| Low Target | USD 7 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (TLSI)
| Next Earnings Date | 2026-11-12 |
|---|---|
| Revenue Estimate | $14.03M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.16 vs est -0.16 ▼ miss |
| 2025-12-31 | USD -0.05 vs est -0.13 ▲ beat |
| 2025-09-30 | USD -0.87 vs est -0.17 ▼ miss |
Source: Nexqual, September 9, 2026 at 12:04 UTC.
Financials & Fundamentals (TLSI)
| Total Revenue | $45.08M |
|---|---|
| Revenue Growth (YoY) | +1.70% |
| Gross Margin | +85.79% |
| Operating Margin | -86.03% |
| Profit Margin | -62.59% |
| Debt / Equity | 525.59 |
| Current Ratio | 5.35 |
| Total Cash | $46.29M |
| Total Debt | $34.43M |
| Free Cash Flow | $-10.88M |
Source: Nexqual, September 9, 2026 at 12:04 UTC.
Financial Health Score (TLSI)
Nexqual rates TLSI's overall financial health "Mixed" across five dimensions, as of September 9, 2026 at 12:04 UTC.
| Growth | Strong — Revenue +53% YoY (annual) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Weak — $46M cash vs $34M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$11M, burning cash |
| Efficiency | Mixed — No data |
Ownership (TLSI)
| Insider Ownership | +33.96% |
|---|---|
| Institutional Ownership | +35.71% |
| Shares Outstanding | 61.57M |
| Float | 49.50M |
| Short % of Float | +8.12% |
Source: Nexqual, September 9, 2026 at 12:04 UTC.
Leadership (TLSI)
TLSI is led by Mary T. Szela B.S.N. (age 61), CEO, President & Director, per Nexqual as of September 9, 2026 at 12:04 UTC.
| CEO, President & Director | Mary T. Szela B.S.N. (age 61) |
|---|---|
| Chief Financial Officer | David B. Patience (age 39) |
| Vice President of Marketing | Andrea Marasso |
Major Backers & Investors (TLSI)
Notable institutional backers of TLSI include First Light Asset Management, LLC, Cerity Partners LLC, Nantahala Capital Management, LLC, according to Nexqual as of September 9, 2026 at 12:04 UTC.
Active Investors
| Investor | Stake |
|---|---|
| First Light Asset Management, LLC | 10.64% |
| Cerity Partners LLC | 2.6% |
| Nantahala Capital Management, LLC | 1.62% |
| Gilder Gagnon Howe & Co LLC | 1.38% |
| Fidelity | 1.22% |
| White Pine Capital LLC | 0.89% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 7.12% |
| Vanguard Group | 5.78% |
| Geode Capital | 1.93% |
| State Street | 0.99% |
Source: Nexqual, September 9, 2026 at 12:04 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OBIO | Orchestra BioMed Holdings, Inc. | USD 5.43 | ▲ 14.56% |
| TKNO | Alpha Teknova, Inc. | USD 6.88 | ▼ 4.97% |
| ESLA | Estrella Immunopharma, Inc. | USD 0.64 | ▼ 0.16% |
| NYXH | Nyxoah SA | USD 1.56 | ▼ 11.36% |
| ZURA | Zura Bio Limited | USD 6.13 | ▲ 4.25% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 12:04 UTC. This page is informational and not investment advice.